Physician
Nephrology
Dr. Emmanuel L. Bravo, MD
|
|
Give Review
Emmanuel L. Bravo works in the field of Nephrology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Emmanuel L. Bravo is a published physician. He published 95 publications, including: 'Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.' He accepts Medicare.
Publications
- Biochemical and radiological relationships in patients With pheochromocytoma: lessons from a case control study.
- Aldosterone Breakthrough during Angiotensin Receptor Blocker Use: More Questions than Answers?
- Resistant Hypertension: Diagnostic strategies and management.
- Change in adRenal mass size as a predictor of a malignant tumor.
- New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressure.
- Renal denervation for resistant hypertension.
- Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adRenal adenomas/hyperplasias from nonadenomas: Cleveland Cli...
- Aldosterone and specific aldosterone receptor antagonists in Hypertension and cardiovascular disease.
- Laparoscopic bilateral partial adRenalectomy for pheochromocytoma.
- Robotic-assisted laparoscopic adRenalectomy.
- Pheochromocytoma: an approach to antiHypertensive management.
- What is the best diagnostic approach when pheochromocytoma is suspected?
- In vitro and in vivo evidence for an indirect mechanism mediating enhanced aldosterone secretion by metoclopramide.
- Hypokalemia, in Bartter''s syndrome and other disorders, produces resistance to vasopressors via prostaglandin overproduction.
- An unusual frontal ganglioglioma: CT and MRI.
- Long-term control of congestive heart Failure with captopril.
- Captopril in congestive heart Failure resistant to other vasodilators.
- Volume-dependent essential and steroid Hypertension.
- The sympathetic nervous system and Hypertension in primary aldosteronism.
- Clinical aspects of endocrine Hypertension.
- Comparative studies of the humoral and arterial pressure responses to Sar1-Ala8-, Sar1-Ile8 and Sar1-Thr8-angiotensin II in the trained unanaesthetized dog.
- Nifedipine gastrointestinal therapeutic system in the treatment of Hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (...
- Endocrine and renal effects of nifedipine gastrointestinal therapeutic system in patients With essential hypertension. Results of a multicenter trial. The Modern Appro...
- Haemodynamic effects of propranolol in Hypertension: a review.
- Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid Hypertension in the intact dog.
- Hemodynamics of essential Hypertension in young subjects.
- Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in Hypertensive patients.
- Hypertension in obese patients: hemodynamic and volume studies.
- Relation of cardiovascular response to the hypotensive effect of metoprolol.
- Constrasts and similarities of Acute hemodynamic responses to specific antagonism of angiotensin II ([Sar1, Thr8] A II) and to inhibition of converting enzyme (captopr...
- Medical intelligence drug therapy: captopril.
- Hemodynamics of a new angiotensin antagonist, [Sar1, Thr8]A II, in Hypertensive man.
- Testosterone-induced 18-hydroxylase block: a new form of steroid Hypertension in man.
- Primary aldosteronism caused by adRenal cortical carcinoma.
- Beta-adrenergic blockade in diuretic-treated patients With essential hypertension.
- Phenylpropanolamine and other over-the-counter vasoactive compounds.
- Individualizing drug therapy for the Hypertensive patient.
- Possible role of cardioaortic reflexes in postcoronary bypass Hypertension.
- Plasma catecholamine responses to physiologic stimuli in normal human pregnancy.
- Hyperpigmentation on cortisone after adRenalectomy for primary aldosteronism.
- Primary hyperaldosteronism: comparison of CT, adRenal venography, and venous sampling.
- Multifactorial analysis of Chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.
- The effect of subarachnoid hemorrhage on blood and CSF atrial natriuretic factor.
- Physiology of the adRenal cortex.
- Humoral responses to intracerebroventricularly administered angiotensin II in dogs.
- Clinical and systemic hemodynamic effects of nitrendipine.
- Hemodynamic and antiHypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
- Hemodynamic and volume changes associated With captopril.
- Long-term converting enzyme inhibition and sympathetic nerve function in Hypertensive humans.
- On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade With propranolol.
- Abnormal membrane sodium transport in Liddle''s syndrome.
- Isolation of a Hypertension-producing compound from normal human urine.
- Converting enzyme inhibition With an orally active compound in hypertensive man.
- Action of (1-des(aspartic acid), 8-isoleucine) angiotensin II upon the pressor and steroidogenic activity of angiotensin II.
- Impaired Renal prostaglandin E2 biosynthesis in human hypertensive states.
- Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction With captopril.
- Localization of autonomic nervous system dysfunction in dialysis patients.
- Evaluation of a simplified technic for the measurement of aldosterone in human urine.
- A quantitative gas-liquid chromatographic method for aldosterone in human urine.
- Primary aldosteronism. Issues in diagnosis and management.
- A carotid body and glomus jugulare paraganglioma secreting norepinephrine.
- Spironolactone as a nonspecific treatment for primary aldosteronism.
- Hemodynamic characteristics of primary aldosteronism.
- Secondary Hypertension. A streamlined approach to diagnosis.
- Fentanyl stimulates atrial natriuretic peptide secretion.
- Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension.
- Malignant pheochromocytoma of the anterior mediastinum: PET findings With [18F]FDG and 82Rb.
- Evaluation of plasma catecholamines in humans. Correlation of resting levels With cardiac responses to beta-blocking and sympatholytic drugs.
- Plasma catecholamines in clinical investigation: a useful index or a meaningless number?
- Excessive sodium retention as a characteristic of salt-sensitive Hypertension.
- Differential diagnosis of etiologic types of Hypertension.
- Plasma and extracellular fluid volumes in Hypertension.
- The changing clinical spectrum of primary aldosteronism.
- Steroidogenic properties of a new aldosterone-stimulating factor: interaction With angiotensin II and adrenocorticotropin during variations of dietary sodium.
- Predictive value of angiotensin II antagonists in renovascular Hypertension.
- Metabolic factors and the sympathetic nervous system.
- Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
- Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential Hypertension.
- Early hemodynamic and humoral effects of lofexidine.
- Plasma catecholamines in clinical medicine.
- Plasma or urinary metanephrines for the diagnosis of pheochromocytoma? That is the question.
- Plasma volume and its regulatory factors in congestive heart Failure after implantation of long-term left ventricular assist devices.
- Predictive value of angiotensin II blockade With (sarcosine-1, threonine-8) angiotensin II in renovascular hypertension.
- Preload, adrenergic activity, and aortic compliance in normal and Hypertensive patients.
- Localization of pheochromocytoma by computed tomography.
- Impaired aldosterone production by Chronic intravenous infusion of atrial natriuretic factor in rabbits.
- Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
- Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.
- Effect of the implantable left ventricular assist device on neuroendocrine activation in heart Failure.
- Hypertensive mechanisms associated With centrally administered aldosterone in dogs.
- Blood pressure regulation in pheochromocytoma.
- Effects of clonidine on sympathetic function.
- Physiologic characteristics of Hypertension.
- Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart Failure.
Schools
University Of The EastRamon Magsaysay Memorial Medical Center University Of The East
St Vincent Char Hsp H Center
University Hospital Of Cleveland
Conditions Treated
- Acute Kidney Failure
- Chronic Kidney Diseases
- Diabetes With Renal Manifestations
- Gout
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Case Western Reserve University - University Hospitals
Drug Facts
| NPI NUMBER | 1760565238 | |
| NPPES Provider LastName | BRAVO | |
| NPPES Provider FirstName | EMMANUEL | |
| NPPES Provider ZIPCode | 441952139 | |
| NPPES Provider State | OH | |
| Specialty Description | General Practice | |
| Total Claim Count | 176.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760565238 |
| Last Name Of The Provider | BRAVO |
| First Name Of The Provider | EMMANUEL |
| View All |
Similar Doctors
|
|
Dr. Keuck Chang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirela A. Dobre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Fissell IV, MD |
|
|
Dr. James F. Simon, MD |
|
|
Dr. Anne M. Huml, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aparna Padiyar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Zipp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shalini Bumb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Lanning Jr., MD
This Doctor is OpenDoctor Recommended.
|